395
Views
115
CrossRef citations to date
0
Altmetric
Review

Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside

, &
Pages 3077-3086 | Published online: 05 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Min Tang, Sho Sakasai, Hiraku Onishi, Kumi Kawano & Yoshiyuki Hattori. (2023) Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor. Journal of Drug Targeting 31:1, pages 74-88.
Read now
Ludger M. Ickenstein & Patrick Garidel. (2019) Lipid-based nanoparticle formulations for small molecules and RNA drugs. Expert Opinion on Drug Delivery 16:11, pages 1205-1226.
Read now
Aditya Kiran Gatta, Raghu Chandrashekhar Hariharapura, Nayanabhirama Udupa, Meka Sreenivasa Reddy & Venkata Rao Josyula. (2018) Strategies for improving the specificity of siRNAs for enhanced therapeutic potential. Expert Opinion on Drug Discovery 13:8, pages 709-725.
Read now

Articles from other publishers (112)

Iman M. Alfagih. 2023. Liposomes - Recent Advances, New Perspectives and Applications. Liposomes - Recent Advances, New Perspectives and Applications.
Eman M. Hassan, Samantha McWhirter, Gilbert C. Walker, Yadienka Martinez-Rubi & Shan Zou. (2023) Elimination of Cancer Cells in Co-Culture: Role of Different Nanocarriers in Regulation of CD47 and Calreticulin-Induced Phagocytosis. ACS Applied Materials & Interfaces 15:3, pages 3791-3803.
Crossref
Priya Yadav, Suresh V. Ambudkar & N. Rajendra Prasad. (2022) Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. Journal of Nanobiotechnology 20:1.
Crossref
Yoshiyuki Hattori, Hiromu Saito, Kayo Nakamura, Ayaka Yamanaka, Min Tang & Kei-ichi Ozaki. (2022) In vitro and in vivo transfections using siRNA lipoplexes prepared by mixing siRNAs with a lipid-ethanol solution. Journal of Drug Delivery Science and Technology 75, pages 103635.
Crossref
Jinxing Huang & Kai Xiao. (2022) Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology. Pharmaceutics 14:8, pages 1586.
Crossref
Savan K. Patel, Margaret M. Billingsley, Caitlin Frazee, Xuexiang Han, Kelsey L. Swingle, Jingya Qin, Mohamad-Gabriel Alameh, Karin Wang, Drew Weissman & Michael J. Mitchell. (2022) Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells. Journal of Controlled Release 347, pages 521-532.
Crossref
Britt Delnoy, Minela Haskovic, Jo Vanoevelen, Laura K. M. Steinbusch, Esther Naomi Vos, Kèvin Knoops, Luc J. I. Zimmermann, Marek Noga, Dirk J. Lefeber, Paolo G. V. Martini, Ana I. Coelho & Maria Estela Rubio‐Gozalbo. (2022) Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classic galactosemia . Journal of Inherited Metabolic Disease 45:4, pages 748-758.
Crossref
Yoshiyuki Hattori, Min Tang, Satomi Torii, Kana Tomita, Ayane Sagawa, Nodoka Inoue, Reo Yamagishi & Kei-Ichi Ozaki. (2022) Optimal combination of cationic lipid and phospholipid in cationic liposomes for gene knockdown in breast cancer cells and mouse lung using siRNA lipoplexes. Molecular Medicine Reports 26:2.
Crossref
Alicia Davis, Kevin V. Morris & Galina Shevchenko. (2022) Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles. Molecular Therapy - Methods & Clinical Development 25, pages 158-169.
Crossref
Amanda-Lee Ezra Manicum, Saman Sargazi, Sobia Razzaq, Govindarajan Venkat Kumar, Abbas Rahdar, Simge Er, Qurrat Ul Ain, Muhammad Bilal & M. Ali Aboudzadeh. (2022) Nano-immunotherapeutic strategies for targeted RNA delivery: Emphasizing the role of monocyte/macrophages as nanovehicles to treat glioblastoma multiforme. Journal of Drug Delivery Science and Technology 71, pages 103288.
Crossref
Yi-Yang Peng, Haimei Hu, Diana Diaz-Dussan, Jianyang Zhao, Xiaojuan Hao & Ravin Narain. (2022) Glycopolymer–Cell-Penetrating Peptide (CPP) Conjugates for Efficient Epidermal Growth Factor Receptor (EGFR) Silencing. ACS Macro Letters 11:4, pages 580-587.
Crossref
Syed Nasir Abbas Bukhari. (2022) Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. Pharmaceutics 14:4, pages 866.
Crossref
Kazuya Nakamura, Keisuke AiharaTatsuhiro Ishida. (2022) Importance of Process Parameters Influencing the Mean Diameters of siRNA-Containing Lipid Nanoparticles (LNPs) on the <i>in Vitro</i> Activity of Prepared LNPs. Biological and Pharmaceutical Bulletin 45:4, pages 497-507.
Crossref
Ye Cao, Yang Fei Tan, Yee Shan Wong, Muhammad Aminuddin, Bhuthalingam Ramya, Melvin Wen Jie Liew, Jiaxin Liu & Subbu S. Venkatraman. (2022) Designing siRNA/chitosan-methacrylate complex nanolipogel for prolonged gene silencing effects. Scientific Reports 12:1.
Crossref
Yanxue Liu, Qun Wang, Bowen Liu, Wanli Sun, Yawen Zhang, Yan Li, Zhen Wang, Yixin Wang, Shuang Chang, Jiandu Lei & Peng Zhao. (2022) Delivery of siRNA by gold nanoparticles layer by layer for prevention and control of subgroup J avian leukemia virus (ALV-J). Chemical Engineering Journal 430, pages 133076.
Crossref
Neha Merchant, Sujatha Peela, Afroz Alam & Ganji Purnachandra Nagaraju. 2022. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 161 174 .
Imran Vhora & Nirav Khatri. 2021. Nanotechnology in Medicine. Nanotechnology in Medicine 195 232 .
Davood Kharaghani, Eben Bashir Kurniwan, Muhammad Qamar Khan & Yuji Yoshiko. (2021) MiRNA-Nanofiber, the Next Generation of Bioactive Scaffolds for Bone Regeneration: A Review. Micromachines 12:12, pages 1472.
Crossref
Rumiana Tenchov, Robert Bird, Allison E. Curtze & Qiongqiong Zhou. (2021) Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano 15:11, pages 16982-17015.
Crossref
Jaemun Kim, Ji Yul Kim, Hyeonkyeong Kim, Eunsil Kim, Soonyong Park, Kyoung-Hwa Ryu & Eun Gyo Lee. (2021) Increasing Transfection Efficiency of Lipoplexes by Modulating Complexation Solution for Transient Gene Expression. International Journal of Molecular Sciences 22:22, pages 12344.
Crossref
Xu Wan, Runzhou Sun, Yun Bao, Chi Zhang, Ying Wu & Yanling Gong. (2021) In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modified Redox Responsive PEG–PEI Nanoparticles for the Treatment of Triple-Negative Breast Cancer . Molecular Pharmaceutics 18:11, pages 3990-3998.
Crossref
Patrick Connerty, Ernest Moles, Charles E. de Bock, Nisitha Jayatilleke, Jenny L. Smith, Soheil Meshinchi, Chelsea Mayoh, Maria Kavallaris & Richard B. Lock. (2021) Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. Pharmaceutics 13:10, pages 1681.
Crossref
Jun Wei, Eli Gilboa, George A. Calin & Amy B. Heimberger. (2021) Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment. Frontiers in Oncology 11.
Crossref
Dima Hattab, Amirah Mohd Gazzali & Athirah Bakhtiar. (2021) Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment. Pharmaceutics 13:7, pages 1009.
Crossref
O. V. Zaborova, A. D. Voinova, B. D. Shmykov & V. G. Sergeyev. (2022) Solid Lipid Nanoparticles for the Nucleic Acid Encapsulation. Reviews and Advances in Chemistry 11:3-4, pages 178-188.
Crossref
Cheng Yu, Long Li, Pei Hu, Yan Yang, Wei Wei, Xin Deng, Lu Wang, Franklin R. Tay & Jingzhi Ma. (2021) Recent Advances in Stimulus‐Responsive Nanocarriers for Gene Therapy. Advanced Science 8:14, pages 2100540.
Crossref
Nigel Davies, Daniel Hovdal, Nicholas Edmunds, Peter Nordberg, Anders Dahlén, Aleksandra Dabkowska, Marianna Yanez Arteta, Aurel Radulescu, Tomas Kjellman, Andreas Höijer, Frank Seeliger, Elin Holmedal, Elisabeth Andihn, Nils Bergenhem, Ann-Sofie Sandinge, Camilla Johansson, Leif Hultin, Marie Johansson, Johnny Lindqvist, Liselotte Björsson, Yujia Jing, Stefano Bartesaghi, Lennart Lindfors & Shalini Andersson. (2021) Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein. Molecular Therapy - Nucleic Acids 24, pages 369-384.
Crossref
Yu Xia, Guoyi Tang, Yi Chen, Changbing Wang, Min Guo, Tiantian Xu, Mingqi Zhao & Yongjian Zhou. (2021) Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma. Bioactive Materials 6:5, pages 1330-1340.
Crossref
Ina F. de la Fuente, Shraddha S. Sawant, Mark Q. Tolentino, Patrick M. Corrigan & Jessica L. Rouge. (2021) Viral Mimicry as a Design Template for Nucleic Acid Nanocarriers. Frontiers in Chemistry 9.
Crossref
Lidya SalimJean-Paul Desaulniers. (2021) To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors. Nucleic Acid Therapeutics 31:1, pages 21-38.
Crossref
Xuemei Ge, Lijuan Chen, Bo Zhao & Weien Yuan. (2021) Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA. Frontiers in Pharmacology 11.
Crossref
Huiling Song, Stephen L. Hart & Zixiu Du. (2021) Assembly strategy of liposome and polymer systems for siRNA delivery. International Journal of Pharmaceutics 592, pages 120033.
Crossref
Jie Li, Joachim Justad Røise, Maomao He, Riddha Das & Niren Murthy. (2021) Non-viral strategies for delivering genome editing enzymes. Advanced Drug Delivery Reviews 168, pages 99-117.
Crossref
Soheil Tavakolpour & Fatemeh Karami. 2021. Cancer Immunology. Cancer Immunology 465 508 .
Kenichi Aburai, Kentaro Hatanaka, Shin Takano, Shota Fujii & Kazuo Sakurai. (2020) Characterizing an siRNA-Containing Lipid-Nanoparticle Prepared by a Microfluidic Reactor: Small-Angle X-ray Scattering and Cryotransmission Electron Microscopic Studies. Langmuir 36:42, pages 12545-12554.
Crossref
Dima Hattab & Athirah Bakhtiar. (2020) Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements. Pharmaceutics 12:10, pages 929.
Crossref
Yoshiyuki Hattori, Kyoko Tamaki, Sho Sakasai, Kei‑Ichi Ozaki & Hiraku Onishi. (2020) Effects of PEG anchors in PEGylated siRNA lipoplexes on in�vitro gene‑silencing effects and siRNA biodistribution in mice. Molecular Medicine Reports.
Crossref
Jae Il Joo, Minsoo Choi, Seong‐Hoon Jang, Sea Choi, Sang‐Min Park, Dongkwan Shin & Kwang‐Hyun Cho. (2020) Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering. Advanced Materials 32:35, pages 1906783.
Crossref
Praveesuda Michael, Yuen Ting Lam, Elysse C. Filipe, Richard P. Tan, Alex H. P. Chan, Bob S. L. Lee, Nicolas Feng, Juichien Hung, Thomas R. Cox, Miguel Santos & Steven G. Wise. (2020) Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivo. Scientific Reports 10:1.
Crossref
Joost van Haasteren, Jie Li, Olivia J. Scheideler, Niren Murthy & David V. Schaffer. (2020) The delivery challenge: fulfilling the promise of therapeutic genome editing. Nature Biotechnology 38:7, pages 845-855.
Crossref
Jianxian Chen, Akram Ashames, Manal Ali Buabeid, Khairi Mustafa Fahelelbom, Muhammad Ijaz & Ghulam Murtaza. (2020) Nanocomposites drug delivery systems for the healing of bone fractures. International Journal of Pharmaceutics 585, pages 119477.
Crossref
Sara C. Humphreys, Mai B. Thayer, Jabbar Campbell, Wen Li Kelly Chen, Dan Adams, Julie M. Lade & Brooke M. Rock. (2020) Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development. Journal of Medicinal Chemistry 63:12, pages 6407-6422.
Crossref
Dominic W. Malcolm, Yuchen Wang, Clyde Overby, Maureen Newman & Danielle S. W. Benoit. (2020) Delivery of RNAi-Based Therapeutics for Bone Regeneration. Current Osteoporosis Reports 18:3, pages 312-324.
Crossref
Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner & Yvonne Perrie. (2020) Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines. Vaccines 8:2, pages 212.
Crossref
Dominique Leboeuf, Tatiana Abakumova, Tatiana Prikazchikova, Luke Rhym, Daniel G. Anderson, Timofei S. Zatsepin & Konstantin I. Piatkov. (2020) Downregulation of the Arg/N-degron Pathway Sensitizes Cancer Cells to Chemotherapy In Vivo. Molecular Therapy 28:4, pages 1092-1104.
Crossref
Phei Er Saw & Er-Wei Song. (2019) siRNA therapeutics: a clinical reality. Science China Life Sciences 63:4, pages 485-500.
Crossref
Seounghun Kang, Jun Kim, Minchul Ahn, Jungho Kim, Myeong-Gang Heo, Dal-Hee Min & Cheolhee Won. (2020) RNAi nanotherapy for fibrosis: highly durable knockdown of CTGF/CCN-2 using siRNA-DegradaBALL (LEM-S401) to treat skin fibrotic diseases. Nanoscale 12:11, pages 6385-6393.
Crossref
Patty Wong, Lin Li, Junie Chea, Weidong Hu, Erasmus Poku, Todd Ebner, Nicole Bowles, Jeffrey Y. C. Wong, Paul J. Yazaki, Stephen Sligar & John E. Shively. (2020) Antibody Targeted PET Imaging of 64 Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors . Bioconjugate Chemistry 31:3, pages 743-753.
Crossref
Mafalda A. Videira, Jordi Llop, Carolina Sousa, Bruna Kreutzer, Unai Cossío, Ben Forbes, Isabel Vieira, Nuno Gil & Beatriz Silva-Lima. (2020) Pulmonary Administration: Strengthening the Value of Therapeutic Proximity. Frontiers in Medicine 7.
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Seiki Shirai, Meito Shibuya, Atsushi Kawai, Shigeyuki Tamiya, Lisa Munakata, Daiki Omata, Ryo Suzuki, Taiki Aoshi & Yasuo Yoshioka. (2020) Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus. Frontiers in Immunology 10.
Crossref
Marcel Scheideler, Ivan Vidakovic & Ruth Prassl. (2020) Lipid nanocarriers for microRNA delivery. Chemistry and Physics of Lipids 226, pages 104837.
Crossref
Nuphar Veiga, Yael Diesendruck & Dan Peer. (2020) Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes. Advanced Drug Delivery Reviews 159, pages 364-376.
Crossref
Yong-Jiang Li, Jun-Yong Wu, Jie-Min Wang, Xiong-Bin Hu, Jia-Xin Cai & Da-Xiong Xiang. (2020) Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. Acta Biomaterialia 101, pages 519-530.
Crossref
João Cortinhas, Ana P. Pêgo & Pedro M.D. Moreno. 2020. Handbook of Innovations in Central Nervous System Regenerative Medicine. Handbook of Innovations in Central Nervous System Regenerative Medicine 333 374 .
Melanie A. Fuller & Ingo Köper. (2019) Biomedical applications of polyelectrolyte coated spherical gold nanoparticles. Nano Convergence 6:1.
Crossref
Worapol Ngamcherdtrakul & Wassana Yantasee. (2019) siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion. Translational Research 214, pages 105-120.
Crossref
Md Abdus Subhan & V.P. Torchilin. (2019) Efficient nanocarriers of siRNA therapeutics for cancer treatment. Translational Research 214, pages 62-91.
Crossref
I. V. Chernikov, U. A. Karelina, M. I. Meschaninova, A. G. Ven’yaminova, M. A. Zenkova, V. V. Vlassov & E. L. Chernolovskaya. (2020) Investigation of the Internalization of Fluorescently Labeled Lipophilic siRNA into Cultured Tumor Cells. Russian Journal of Bioorganic Chemistry 45:6, pages 766-773.
Crossref
Edward J. Sayers, Samantha E. Peel, Anna Schantz, Richard M. England, Maya Beano, Stephanie M. Bates, Arpan S. Desai, Sanyogitta Puri, Marianne B. Ashford & Arwyn T. Jones. (2019) Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression. Molecular Therapy 27:11, pages 1950-1962.
Crossref
Brian TruongGabriella AllegriXiao-Bo LiuKristine E. BurkeXuling ZhuStephen D. Cederbaum, Johannes HäberlePaolo G. V. MartiniGerald S. Lipshutz. (2019) Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency. Proceedings of the National Academy of Sciences 116:42, pages 21150-21159.
Crossref
Daniel Bullock, Aaron Jesuthasan, Rafael González-Cano & Michael Costigan. (2019) Reading and writing: the evolution of molecular pain genetics. Pain 160:10, pages 2177-2185.
Crossref
Weiyu Zhao, Xucheng Hou, Olivia G. Vick & Yizhou Dong. (2019) RNA delivery biomaterials for the treatment of genetic and rare diseases. Biomaterials 217, pages 119291.
Crossref
Uma Kavita, Wendy Miller, Qin C. Ji & Renuka C. Pillutla. (2019) A Fit-for-Purpose Method for the Detection of Human Antibodies to Surface-Exposed Components of BMS-986263, a Lipid Nanoparticle-Based Drug Product Containing a siRNA Drug Substance. The AAPS Journal 21:5.
Crossref
Cornelia Lorenzer, Sonja Streußnig, Emilia Tot, Anna-Maria Winkler, Hannes Merten, Fabian Brandl, Edward J. Sayers, Peter Watson, Arwyn T. Jones, Uwe Zangemeister-Wittke, Andreas Plückthun & Johannes Winkler. (2019) Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencing. European Journal of Pharmaceutics and Biopharmaceutics 141, pages 37-50.
Crossref
Anna Angela Barba, Sabrina Bochicchio, Annalisa Dalmoro & Gaetano Lamberti. (2019) Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications. Pharmaceutics 11:8, pages 360.
Crossref
John W. Loughney, Kevin Minsker, Sha Ha & Richard R. Rustandi. (2019) Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. ELECTROPHORESIS.
Crossref
Christina Chan, Nining Guo, Xiaopin Duan, Wenbo Han, Lai Xue, Darren Bryan, Sean C. Wightman, Nikolai N. Khodarev, Ralph R. Weichselbaum & Wenbin Lin. (2019) Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer. Biomaterials 210, pages 94-104.
Crossref
Eunshil Choi, Juyong Lee, Ick Chan Kwon, Dong-Kwon Lim & Sehoon Kim. (2019) Cumulative directional calcium gluing between phosphate and silicate: A facile, robust and biocompatible strategy for siRNA delivery by amine-free non-positive vector. Biomaterials 209, pages 126-137.
Crossref
Radu Mihaila, Dipali Ruhela, Beverly Galinski, Ananda Card, Mark Cancilla, Timothy Shadel, Jing Kang, Samnang Tep, Jie Wei, R. Matthew Haas, Jeremy Caldwell, W. Michael Flanagan, Nelly Kuklin, Elena Cherkaev & Brandon Ason. (2019) Modeling the Kinetics of Lipid-Nanoparticle- Mediated Delivery of Multiple siRNAs to Evaluate the Effect on Competition for Ago2. Molecular Therapy - Nucleic Acids 16, pages 367-377.
Crossref
Ali Rastegari, Fatemeh Mottaghitalab, Rassoul Dinarvand, Mohsen Amini, Ehsan Arefian, Mahdi Gholami & Fatemeh Atyabi. (2019) Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid. Drug Delivery and Translational Research 9:3, pages 694-706.
Crossref
Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada & Amy C. H. Lee. (2018) Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model. ACS Infectious Diseases 5:5, pages 738-749.
Crossref
Emily P. Thi, Ammen P. Dhillon, Andrzej Ardzinski, Lale Bidirici-Ertekin, Kyle D. Cobarrubias, Andrea Cuconati, Andrew S. Kondratowicz, Kaylyn Kwak, Alice H. L. Li, Angela Miller, Chris Pasetka, Luying Pei, Janet R. Phelps, Nicholas M. Snead, Xiaohe Wang, Xin Ye, Michael J. Sofia & Amy C. H. Lee. (2018) ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection. ACS Infectious Diseases 5:5, pages 725-737.
Crossref
Imran Vhora, Rohan Lalani, Priyanka Bhatt, Sushilkumar Patil & Ambikanandan Misra. (2019) Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction. International Journal of Pharmaceutics 563, pages 324-336.
Crossref
Padmanaban Sivakumar, Sumin Kim, Han Chang Kang & Min Suk Shim. (2018) Targeted siRNA delivery using aptamer‐siRNA chimeras and aptamer‐conjugated nanoparticles. WIREs Nanomedicine and Nanobiotechnology 11:3.
Crossref
Ivan V. Chernikov, Valentin V. Vlassov & Elena L. Chernolovskaya. (2019) Current Development of siRNA Bioconjugates: From Research to the Clinic. Frontiers in Pharmacology 10.
Crossref
Manisit DasSara MusettiLeaf Huang. (2019) RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise. Nucleic Acid Therapeutics 29:2, pages 61-66.
Crossref
Wei Yin & Mark Rogge. (2019) Targeting RNA : A Transformative Therapeutic Strategy . Clinical and Translational Science 12:2, pages 98-112.
Crossref
Cristina Ana Constantinescu, Elena Valeria Fuior, Daniela Rebleanu, Mariana Deleanu, Viorel Simion, Geanina Voicu, Virginie Escriou, Ileana Manduteanu, Maya Simionescu & Manuela Calin. (2019) Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells. Pharmaceutics 11:1, pages 47.
Crossref
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte, Virginie Malard, Hamida Hammad, Patrick Baril, Thierry Benvegnu, Paul-Alain Jaffrès, Sander A. A. Kooijmans, Raymond Schiffelers, Stefan Lienenklaus, Patrick Midoux, Chantal Pichon, Karine Breckpot & Kris Thielemans. (2018) Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety. ACS Nano 12:10, pages 9815-9829.
Crossref
Wesley D Robertson, Hartmut Schlüter, RJ Dwayne Miller & Qin C Ji. (2018) New frontiers in drug development utilizing desorption by impulsive vibrational excitation for sample preparation, tissue imaging and beyond. Bioanalysis 10:20, pages 1625-1629.
Crossref
Maja M. Janas, Carole E. Harbison, Victoria K. Perry, Brenda Carito, Jessica E. Sutherland, Akshay K. Vaishnaw, Natalie D. Keirstead & Garvin Warner. (2018) The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies. Toxicologic Pathology 46:7, pages 735-745.
Crossref
Ruchi JainJosh P. FrederickEric Y. HuangKristine E. BurkeDavid M. MaugerElizaveta A. AndrianovaSam J. FarlowSummar SiddiquiJeffrey PimentelKahlin Cheung-OngKristine M. McKinneyCaroline KöhrerMelissa J. MooreTirtha Chakraborty. (2018) MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct. Nucleic Acid Therapeutics 28:5, pages 285-296.
Crossref
Qingqing Xiong, Gha Young Lee, Jianxun Ding, Wenliang Li & Jinjun Shi. (2018) Biomedical applications of mRNA nanomedicine. Nano Research 11:10, pages 5281-5309.
Crossref
Xueguang Lu & Ke Zhang. (2018) PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures. Nano Research 11:10, pages 5519-5534.
Crossref
Jason B. Miller & Daniel J. Siegwart. (2018) Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing. Nano Research 11:10, pages 5310-5337.
Crossref
Jilong Li, Subhadip Ghatak, Mohamed S. El Masry, Amitava Das, Yang Liu, Sashwati Roy, Robert J. Lee & Chandan K. Sen. (2018) Topical Lyophilized Targeted Lipid Nanoparticles in the Restoration of Skin Barrier Function following Burn Wound. Molecular Therapy 26:9, pages 2178-2188.
Crossref
Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan Tavernier, Stefaan De Koker & Xavier Saelens. (2018) Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes. Nature Communications 9:1.
Crossref
Mikhail Durymanov & Joshua Reineke. (2018) Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers. Frontiers in Pharmacology 9.
Crossref
Rahul R. Nikam & Kiran R. Gore. (2018) Journey of siRNA: Clinical Developments and Targeted Delivery. Nucleic Acid Therapeutics 28:4, pages 209-224.
Crossref
Julia Poletaeva, Ilya Dovydenko, Anna Epanchintseva, Kseniya Korchagina, Dmitrii Pyshnyi, Evgeny Apartsin, Elena Ryabchikova & Inna Pyshnaya. (2018) Non-Covalent Associates of siRNAs and AuNPs Enveloped with Lipid Layer and Doped with Amphiphilic Peptide for Efficient siRNA Delivery. International Journal of Molecular Sciences 19:7, pages 2096.
Crossref
Clay PattonGist H. FarrIIIIIIDing AnPaolo G.V. MartiniLisa Maves. (2018) Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish. Zebrafish 15:3, pages 217-227.
Crossref
Maire F. OsbornAnastasia Khvorova. (2018) Improving siRNA Delivery In Vivo Through Lipid Conjugation . Nucleic Acid Therapeutics 28:3, pages 128-136.
Crossref
Ludger JohannesMarco Lucchino. (2018) Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs. Nucleic Acid Therapeutics 28:3, pages 178-193.
Crossref
Johannes Winkler. (2018) Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins. Nucleic Acid Therapeutics 28:3, pages 137-145.
Crossref
Yuchen Wang, Maureen R. Newman & Danielle S.W. Benoit. (2018) Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review. European Journal of Pharmaceutics and Biopharmaceutics 127, pages 223-236.
Crossref
Kohei Tahara, Manami Kobayashi, Satoko Yoshida, Risako Onodera, Naoki Inoue & Hirofumi Takeuchi. (2018) Effects of cationic liposomes with stearylamine against virus infection. International Journal of Pharmaceutics 543:1-2, pages 311-317.
Crossref
Haiyang Zhang, Yi Wang, Ming Bai, Junyi Wang, Kegan Zhu, Rui Liu, Shaohua Ge, JiaLu Li, Tao Ning, Ting Deng, Qian Fan, Hongli Li, Wu Sun, Guoguang Ying & Yi Ba. (2018) Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Science 109:3, pages 629-641.
Crossref
Gabriele Romano & Lawrence N. Kwong. (2017) Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy. Cancer and Metastasis Reviews 37:1, pages 45-53.
Crossref
Shruti SasakiShuling Guo. (2018) Nucleic Acid Therapies for Cystic Fibrosis. Nucleic Acid Therapeutics 28:1, pages 1-9.
Crossref
Jianliang Shen, Wei Zhang, Ruogu Qi, Zong-Wan Mao & Haifa Shen. (2018) Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics. Chemical Society Reviews 47:6, pages 1969-1995.
Crossref
Hong Su, Yafei Wang, Yuanliang Gu, Linda Bowman, Jinshun Zhao & Min Ding. (2018) Potential applications and human biosafety of nanomaterials used in nanomedicine. Journal of Applied Toxicology 38:1, pages 3-24.
Crossref
Emily P. Thi, Chad E. Mire, Amy C.H. Lee, Joan B. Geisbert, Raul Ursic-Bedoya, Krystle N. Agans, Marjorie Robbins, Daniel J. Deer, Robert W. Cross, Andrew S. Kondratowicz, Karla A. Fenton, Ian MacLachlan & Thomas W. Geisbert. (2017) siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease. Journal of Clinical Investigation 127:12, pages 4437-4448.
Crossref
Xueyan Cao, Xueguang Lu, Dali Wang, Fei Jia, Xuyu Tan, Michelle Corley, Xiaoying Chen & Ke Zhang. (2017) Modulating the Cellular Immune Response of Oligonucleotides by Brush Polymer‐Assisted Compaction. Small 13:43, pages 1701432.
Crossref
Valentina M. Farzan, Egor A. Ulashchik, Yury V. Martynenko-Makaev, Maksim V. Kvach, Ilya O. Aparin, Vladimir A. Brylev, Tatiana A. Prikazchikova, Svetlana Yu. Maklakova, Alexander G. Majouga, Alexey V. Ustinov, German A. Shipulin, Vadim V. Shmanai, Vladimir A. Korshun & Timofei S. Zatsepin. (2017) Automated Solid-Phase Click Synthesis of Oligonucleotide Conjugates: From Small Molecules to Diverse N -Acetylgalactosamine Clusters . Bioconjugate Chemistry 28:10, pages 2599-2607.
Crossref
Yu Sakurai, Wataru Mizumura, Manami Murata, Tomoya Hada, Shoshiro Yamamoto, Kenichiro Ito, Kazuhiro Iwasaki, Takayuki Katoh, Yuki Goto, Asako Takagi, Michinori Kohara, Hiroaki Suga & Hideyoshi Harashima. (2017) Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting. Molecular Pharmaceutics 14:10, pages 3290-3298.
Crossref
Chit Tam, Jack Ho Wong, Randy Chi Fai Cheung, Tao Zuo & Tzi Bun Ng. (2017) Therapeutic potentials of short interfering RNAs. Applied Microbiology and Biotechnology 101:19, pages 7091-7111.
Crossref
Geoffrey A Pietersz, Xiaowei Wang, May Lin Yap, Bock Lim & Karlheinz Peter. (2017) Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies. Nanomedicine 12:15, pages 1873-1889.
Crossref
Sophia Antimisiaris, Spyridon Mourtas & Konstantina Papadia. (2017) Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential. International Journal of Pharmaceutics 525:2, pages 293-312.
Crossref
Kunal Patel, Carl Atkinson, Danh Tran & Satish N. Nadig. (2017) Nanotechnological Approaches to Immunosuppression and Tolerance Induction. Current Transplantation Reports 4:2, pages 159-168.
Crossref
Nicholas Reynolds, Megan Dearnley & Tracey M. Hinton. (2017) Polymers in the Delivery of siRNA for the Treatment of Virus Infections. Topics in Current Chemistry 375:2.
Crossref
Suvasini RamaswamyNina TonnuKiyoshi Tachikawa, Pattraranee Limphong, Jerel B. Vega, Priya P. Karmali, Pad Chivukula & Inder M. Verma. (2017) Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proceedings of the National Academy of Sciences 114:10.
Crossref